Author Archive: Jason Corum

Jason Corum

Jason is the director of web and new media with the Biotechnology Industry Organization (BIO). Prior to joining BIO in March 2011, he was the online communications manager for World Food Program USA and an online communications specialist with the Brookings Institution.

Jason is originally from Evergreen Park, Ill. and still thinks that Chicago is the best food city in the nation.  He spends his free time volunteering with the DC Books to Prisons Project, watching movies and reading comics.

Latest Posts

The Presidential Inaugural: Looking Back at 30 Years of Biotech Policy Milestones

President Obama

As President Barack Obama prepares for his second inauguration, we decided that it would be a good time to take a look back on some of the most important pieces of legislation enacted by past presidential administrations and Congress with the support of the biotechnology industry. From helping create jobs, to propelling continued innovation and promoting research to find cures for rare diseases, the following pieces of legislation from the past 30 years are some Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

2012 Biotech Gift Guide

xmas-presents

Welcome to this year’s BIOtechNOW Gift Guide, our most loved biotech gift ideas from 2012 and beyond. Here you’ll find gifts that track your genetic history, interesting biotech books, and art! So whether you’re looking for a last-minute gift idea or a way to blow part of that holiday bonus consider this your guide to yuletide biotech bliss! Add your suggestions in the comments! 23andMe 23andMe is a DNA analysis service providing information and tools Read More >

Corporate  |  Leave a comment  |  Email This Post
Tags: , , , ,

FDASIA: A Step Forward for Patients

fdasia-panel

Earlier this year, Congress passed and President Obama signed the FDA Safety and Innovation Act (FDASIA) which included a re-authorization of the Prescription Drug User Fee Act (PDUFA). PDUFA provides essential funding to the FDA by authorizing the agency to charge user fees to companies seeking to have products reviewed. Originally enacted in 1992, it must be reauthorized every 5 years. Sara Radcliffe, executive vice president of health at BIO, moderated a panel of experts and advocates Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , ,

It Takes a Village: The New Pharma-VC Model for Biotech Investing

bif-hall

High-profile funding collaborations between pharmaceutical companies and traditional venture capital funds have made headlines in recent months, pooling resources and expertise in an attempt to source and develop the most successful drugs. BIO Executive Vice President Alan Eisenberg moderated It Takes a Village: The New Pharma-VC Model for Biotech Investing, a panel discussion about these new funding models, during the opening plenary session at the 2012 BIO Investor Forum. In the past, venture capital could Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

BIO Technology Transfer Symposium: Funding that First $2 Million

2-mill

With creative funding schemes picking up steam and nontraditional funders taking an interest in biotech, what can universities and start-ups expect in their right first-round financing structure? At the BIO Technology Transfer Symposium, a panel examined various funding sources as well as the factors that influence investment decisions and the ins and outs of early stage financing deals. William Tucker, executive director, Innovation Alliances and Services, University of California Office of the President, moderated a Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,